PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 48 filers reported holding PROQR THRAPEUTICS N V in Q4 2020. The put-call ratio across all filers is 13.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $93,000 | -4.1% | 124,424 | -0.7% | 0.09% | +5.7% |
| Q2 2022 | $97,000 | +142.5% | 125,273 | +185.4% | 0.09% | +225.9% |
| Q1 2022 | $40,000 | -81.4% | 43,900 | +63.3% | 0.03% | -80.9% |
| Q4 2021 | $215,000 | +17.5% | 26,875 | +23.1% | 0.14% | +21.6% |
| Q3 2021 | $183,000 | -15.3% | 21,830 | -31.9% | 0.12% | -15.9% |
| Q2 2021 | $216,000 | -5.7% | 32,037 | -7.6% | 0.14% | -11.0% |
| Q1 2021 | $229,000 | +241.8% | 34,654 | +118.6% | 0.16% | +244.4% |
| Q4 2020 | $67,000 | – | 15,855 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 1,237,400 | $5,197,000 | 1.55% |
| Prosight Management, LP | 255,000 | $1,071,000 | 0.50% |
| RTW INVESTMENTS, LP | 5,009,768 | $21,041,000 | 0.35% |
| Kerrisdale Advisers, LLC | 453,182 | $1,903,000 | 0.15% |
| Artal Group S.A. | 1,196,218 | $5,024,000 | 0.11% |
| COWEN AND COMPANY, LLC | 285,696 | $1,200,000 | 0.11% |
| Golden Green, Inc. | 16,999 | $71,000 | 0.07% |
| APOGEM CAPITAL LLC | 15,855 | $67,000 | 0.04% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4,550,062 | $19,110,000 | 0.04% |
| ALTRINSIC GLOBAL ADVISORS LLC | 241,360 | $1,014,000 | 0.03% |